Felix S. Lichtenegger

Author

Also Known As

F. S. Lichtenegger, F.S. Lichtenegger, Felix Lichtenegger, Felix S Lichtenegger, Felix S. Lichtenegger, Lichtenegger, Felix

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

LMU Klinikum Ludwig-Maximilians-Universität München Helmholtz Zentrum München Heidelberg University German Cancer Research Center

About

Felix S. Lichtenegger is an author at LMU Klinikum specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	204
2	Cell Biology	4	4	187
3	Immunology	3	3	116
4	Cellular Therapies	2	2	65
5	Health Sciences	1	1	71

Felix S. Lichtenegger

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML Sascha Haubner, Fabiana Perna, Thomas Köhnke, Leukemia	2018	311
CD33 target validation and sustained depletion of AML blasts in long-term cultures by the bispecific T-cell–engaging antibody AMG 330 Christina Krupka, Peter Kufer, Roman Kischel, Blood	2013	199
Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells Felix S. Lichtenegger, Maurine Rothe, Frauke M. Schnorfeil, Frontiers in Immunology	2018	181
T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment Frauke M. Schnorfeil, Felix S. Lichtenegger, Katharina Emmerig, Journal of Hematology & Oncology	2015	144
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with <scp><i>PCM1</i>‐<i>JAK2</i></scp>, <scp><i>BCR‐JAK2</i></scp> and <scp><i>ETV6‐ABL1</i></scp> fusion genes Juliana Schwaab, Nicole Naumann, Johannes Luebke, American Journal of Hematology Myeloid NeoplasmsMixed-phenotype Acute LeukemiaTyrosine KinaseKinase InhibitorsPathology	2020	71
CD86 and IL-12p70 Are Key Players for T Helper 1 Polarization and Natural Killer Cell Activation by Toll-Like Receptor-Induced Dendritic Cells Felix S. Lichtenegger, Katharina Mueller, Bettina Otte, PLoS ONE	2012	68
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours Ignacio Melero, María de Miguel Luken, Guillermo de Velasco, Nature	2024	68
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody Christian Augsberger, Gerulf Hänel, Wei Xu, Blood	2021	66
Cellular Uptake of Tile-Assembled DNA Nanotubes Samet Kocabey, Hanna Meinl, Iain Macpherson, Nanomaterials	2014	65
Diagnosis of <scp>CLL</scp> revisited: increased specificity by a modified five‐marker scoring system including <scp>CD</scp>200 Thomas Köhnke, Veronika K. Wittmann, Veit Bücklein, British Journal of Haematology	2017	62

Page 1